Pharmaniaga Meloxicam

Pharmaniaga Meloxicam



Pharmaniaga Manufacturing Berhad


Pharmaniaga Logistics
Concise Prescribing Info
Symptomatic treatment of painful OA, RA & ankylosing spondylitis.
Dosage/Direction for Use
OA 7.5 mg daily, may be increased to 15 mg daily. RA 15 mg daily, may be reduced to 7.5 mg daily. Ankylosing spondylitis 15 mg daily. Max dose: 15 mg daily.
May be taken with or without food: May be taken w/ meals if GI discomfort occurs.
Hypersensitivity to acetylsalicylic acid & other NSAIDs. Active peptic ulceration. Severe hepatic & non-dialysed severe renal insufficiency. Pregnancy & lactation. Childn <15 yr.
Special Precautions
Serious GI disease, dehydrated patients, CHF, recent major surgical procedures. W/draw if peptic ulceration or GI bleeding occurs. Hepatic cirrhosis, nephritic syndrome, overt renal disease. Elderly.
Adverse Reactions
GI disturbances, anaemia, pruritus, skin rash, stomatitis, utricaria, lightheadedness, headache, vertigo, tinnitus, drownsiness, confusion, disorientation, oedema, increased BP, palpitations, flushes, acute renal failure, blurred vision, hypersensitivity reactions.
Drug Interactions
NSAIDs, oral anticoagulants, ticlopidine, heparin, thrombolytics, lithium, methotrexate, IUD, diuretics, antihypertensive drugs, cholestyramine, cyclosporin.
ATC Classification
M01AC06 - meloxicam ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, oxicams.
Pharmaniaga Meloxicam tab 7.5 mg
50 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in